Delivery Order SPE2DR25D3016-SPE2DR26FG2DF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, issued with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,745.98 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with a completion deadline of December 16, 2025, with no set-aside designation. The contract represents a competitively awarded transaction under AmerisourceBergen's larger prime contract vehicle with the DLA, reflecting the company's established role as a critical...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for Benlysta 200 mg/mL auto-injector pharmaceutical products. The order is a firm fixed price, non-set-aside contract with a completion date of December 30, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete procurement action under a larger contracting vehicle that enables AmerisourceBergen to supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. This firm fixed-price delivery order, valued at $6,165.36, is scheduled for completion by November 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, demonstrating the contractor's...
- The Defense Logistics Agency awarded a $25,989.28 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 2, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. The award was made on November 4, 2025, with an ultimate completion date of November 26, 2025, under a firm fixed-price delivery order contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on December 1, 2025, with a ceiling value of $12,994.64 and ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Benlysta 200 mg/ml auto-injector medications with a ceiling value of $6,497.32 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by January 2, 2026, with performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the...
- The Defense Logistics Agency awarded a $19,491.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on December 9, 2025, with completion targeted for December 31, 2025. This non-set-aside competitive award represents a single delivery order supporting federal medical procurement needs, with performance based in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. This delivery order is issued...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2DFDelivery Order
The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, leveraging its established role as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The award demonstrates the contractor's capability to meet federal procurement requirements through its established infrastructure and existing contractual framework with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 12/10/25 |